Kidney function study of the antibiotic afabicin
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies how the body handles the antibiotic afabicin in people with different levels of kidney function. It will help determine if the dose needs to be adjusted for people with kidney problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- Your body mass index (BMI) is between 18.5 and 35.0
- You are a nonsmoker and have not used nicotine or tobacco in the past month
- Your kidney function is stable, with an eGFR value from your medical records
- You have not had a serious infection in the past 2 weeks or a history of frequent infections
- You are willing to avoid any investigational drugs for at least 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how the body processes the experimental medicine PF-07328948 in people with different levels of kidney function. It may help find the right dose for people with kidney disease.
This study tests how a new experimental drug (INCB123667) works and is tolerated in adults with severe kidney problems or end-stage kidney disease. Researchers want to understand how the drug moves through the body and whether it's safe for people in your situation.
This study tests a new medicine called RO7795081 in people with different levels of kidney function, including those with kidney problems and those with normal kidneys. It aims to see how safe the medicine is and how the body processes it, which helps doctors decide safe dosing for people with kidney issues.
This study looks at how the kidneys work in both healthy people and those with reduced kidney function. Researchers want to understand kidney health better to help people in the future.
This study tests an IV antibiotic (cefiderocol/xeruborbactam) in people with different levels of kidney function, including those on dialysis. It aims to see how the drug is processed by the body and whether it is safe.
This trial studies how common antibiotics move through the body when someone is on kidney replacement therapy (dialysis), including when dialysis starts during treatment. The results may help doctors choose the right antibiotic dose and timing for better infection treatment.
Hear when a new Renal Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.